Cargando…

High-throughput proteomics profiling-derived signature associated with chemotherapy response and survival for stage II/III colorectal cancer

Adjuvant chemotherapy (ACT) is usually used to reduce the risk of disease relapse and improve survival for stage II/III colorectal cancer (CRC). However, only a subset of patients could benefit from ACT. Thus, there is an urgent need to identify improved biomarkers to predict survival and stratify p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Shu-Biao, Cheng, Yi-Kan, Li, Pei-Si, Zhang, Lin, Zhang, Lian-Hai, Huang, Yan, Chen, Ping, Wang, Yi, Wang, Chao, Peng, Jian-Hong, Shi, Li-Shuo, Ling, Li, Wu, Xiao-Jian, Qin, Jun, Yang, Zi-Huan, Lan, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232411/ https://www.ncbi.nlm.nih.gov/pubmed/37258779 http://dx.doi.org/10.1038/s41698-023-00400-0

Ejemplares similares

An immune, stroma, and epithelial–mesenchymal transition‐related signature for predicting recurrence and chemotherapy benefit in stage II–III colorectal cancer
por: Cai, Du, et al.
Publicado: (2023)

Neoadjuvant chemotherapy by bronchial arterial infusion in patients with unresectable stage III squamous cell lung cancer
por: Zhu, Jun, et al.
Publicado: (2017)

High Throughput Identification of Antihypertensive Peptides from Fish Proteome Datasets
por: Yi, Yunhai, et al.
Publicado: (2018)

High-Throughput Identification of the Plasma Proteomic Signature of Inflammatory Bowel Disease
por: Di Narzo, Antonio F, et al.
Publicado: (2019)

Proteomic signatures of infiltrative gastric cancer by proteomic and bioinformatic analysis
por: Zhang, Li-Hua, et al.
Publicado: (2022)

The Predictive Value of Estrogen Receptor 1 on Adjuvant Chemotherapy in Locally Advanced Colorectal Cancer: A Retrospective Analysis With Independent Validation and Its Potential Mechanism
por: Ye, Shu-Biao, et al.
Publicado: (2020)

Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma
por: Zhang, Xu, et al.
Publicado: (2021)

Addition of Zoledronate to Chemotherapy in Patients with Osteosarcoma Treated with Limb-Sparing Surgery: A Phase III Clinical Trial
por: Li, Shenglong, et al.
Publicado: (2019)

Identification of Benzyloxy Carbonimidoyl Dicyanide Derivatives as Novel Type III Secretion System Inhibitors via High-Throughput Screening
por: Ma, Yi-Nan, et al.
Publicado: (2019)

Natural compound Tan-I enhances the efficacy of Paclitaxel chemotherapy in ovarian cancer
por: Zhou, Jin, et al.
Publicado: (2020)

High-Throughput Identification of Mammalian Secreted Proteins Using Species-Specific Scheme and Application to Human Proteome
por: Zhang, Jian, et al.
Publicado: (2018)

The role of adjuvant chemotherapy in stage I–III male breast cancer: a SEER-based analysis
por: Li, Wei-Ping, et al.
Publicado: (2020)

The Core Proteome and Pan Proteome of Salmonella Paratyphi A Epidemic Strains
por: Zhang, Li, et al.
Publicado: (2014)

Identification and validation of inferior prognostic genes associated with immune signatures and chemotherapy outcome in acute myeloid leukemia
por: Wang, Jie, et al.
Publicado: (2021)

Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features
por: Yang, Nong, et al.
Publicado: (2023)

miRNA Signature in Mouse Spermatogonial Stem Cells Revealed by High-Throughput Sequencing
por: Tan, Tao, et al.
Publicado: (2014)

A preliminary study on the quality of street vended foods around a university in Kunming, China
por: Zhang, Xuechun, et al.
Publicado: (2020)

An Unfolded Protein Response Related Signature Could Robustly Predict Survival Outcomes and Closely Correlate With Response to Immunotherapy and Chemotherapy in Bladder Cancer
por: Zhang, Facai, et al.
Publicado: (2021)

Retracted Article: High-throughput metabolomics identifies serum metabolic signatures in acute kidney injury using LC-MS combined with pattern recognition approach
por: Li, Hai-Hong, et al.
Publicado: (2018)

{μ-6,6′-Dimethoxy-2,2′-[ethane-1,2-diylbis(nitrilomethylidyne)]diphenolato}-μ-nitrato-dinitratoholmium(III)zinc(II)
por: Xiao, Yi-An, et al.
Publicado: (2008)

Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy
por: Peng, Hong, et al.
Publicado: (2019)

A vasculogenic mimicry prognostic signature associated with immune signature in human gastric cancer
por: Wang, Jie, et al.
Publicado: (2022)

Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
por: CUI, HAI-BIN, et al.
Publicado: (2014)

Molecular Markers of MDR of Chemotherapy for HSCC: Proteomic Screening With High-Throughput Liquid Chromatography-Tandem Mass Spectrometry
por: Shen, Bin, et al.
Publicado: (2021)

Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma
por: Zhang, Shan-Qiang, et al.
Publicado: (2022)

FZR1 as a novel biomarker for breast cancer neoadjuvant chemotherapy prediction
por: Liu, Shuo, et al.
Publicado: (2020)

Machine Learning Based on a Multiparametric and Multiregional Radiomics Signature Predicts Radiotherapeutic Response in Patients with Glioblastoma
por: Pan, Zi-Qi, et al.
Publicado: (2020)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Glycolysis Define Two Prognostic Subgroups of Lung Adenocarcinoma With Different Mutation Characteristics and Immune Infiltration Signatures
por: Huo, Chen, et al.
Publicado: (2021)

Proteome changes in mesenteric lymph induced by sepsis
por: ZHANG, PING, et al.
Publicado: (2014)

Predicting Early Intrahepatic Recurrence of Hepatocellular Carcinoma after Microwave Ablation Using SELDI-TOF Proteomic Signature
por: Cao, Xiao-lin, et al.
Publicado: (2013)

Proteomic analysis revealed common, unique and systemic signatures in gender-dependent hepatocarcinogenesis
por: Li, Huiling, et al.
Publicado: (2020)

Cell-based high-throughput screening of polysaccharide biosynthesis hosts
por: Liu, Zi-Xu, et al.
Publicado: (2021)

Neoadjuvant Chemotherapy With CAPOX Versus Chemoradiation for Locally Advanced Rectal Cancer With Uninvolved Mesorectal Fascia (CONVERT): Initial Results of a Phase III Trial
por: Mei, Wei-Jian, et al.
Publicado: (2023)

A circRNA signature predicts postoperative recurrence in stage II/III colon cancer
por: Ju, Huai‐Qiang, et al.
Publicado: (2019)

Identification of Proteomic Signatures in Chronic Obstructive Pulmonary Disease Emphysematous Phenotype
por: Bai, Shuang, et al.
Publicado: (2021)

Phase III trial of docetaxel cisplatin 5‐fluorouracil induction chemotherapy for resectable oral cancer suggests favorable pathological response as a surrogate endpoint for good therapeutic outcome
por: Ju, Wu‐tong, et al.
Publicado: (2021)

Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR)
por: Jin, Jing, et al.
Publicado: (2022)

Comparative Proteomic Analysis of Adhesion/Invasion Related Proteins in Cronobacter sakazakii Based on Data-Independent Acquisition Coupled With LC-MS/MS
por: Li, Ping, et al.
Publicado: (2020)

Genomic signatures define three subtypes of EGFR-mutant stage II–III non-small-cell lung cancer with distinct adjuvant therapy outcomes
por: Liu, Si-Yang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_01j8dnd509roqt3u9oc0t4q7o0